Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: Involvement of different TCRBV subsets

Bone Marrow Transplantation

Volumn 22, Issue 4, 1998, Pages 385-392

  Gaschet, J ^a   Gallot, G ^a   Ibisch, C ^a   Lim, A ^b   Even, J ^b   Vivien, R ^a   Hallet, M M ^a   Milpied, N ^a,c   Vie H ^a,d  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c Centre Hospitalier Régional   (France)

^d INSERM   (France)

Author keywords

GVH; HLA DP; Transplantation

Indexed keywords

CD34 ANTIGEN; HLA DP ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSPLANTATION ANTIGEN;

ADULT; ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SKIN BIOPSY; T LYMPHOCYTE;

EID: 0031718604     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701336     Document Type: Article

References (21)

1. Ferrara JLM, Deeg HL. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
2. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donor for hematologic malignancies. Transplantation 1991; 51: 443-447.
3. Beatty PG, Anasetti C, Hanse JA et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching of one HLA locus. Blood 1993; 81: 249-253.
4. Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute-graft-versus host disease following unrelated bone marrow transplantation. Blood 1993; 81: 1923-1932.
5. Moreau P, Cesbron A. HLA-DP and allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994; 13: 675-681.
6. Gaschet J, Mahe B, Milpied N et al. Specificity of T cell invading the skin during acute graft-versus-host disease after semi-allogenic bone marrow transplantation. J Clin Invest 1993; 91: 12-20.
7. Gaschet J, Trevino MA, Cherel M et al. HLA-target antigen and TCR diversity of activated T cells invading the skin during acute graft-versus-host disease. Blood 1996; 87: 2345-2353.
8. Gaschet J, Lim A, Liem L et al. Acute graft-versus-host disease due to T lymphocytes recognizing a single HLA-DPB1* 0501 mismatch. J Clin Invest 1996; 98: 100-107.
9. Gaschet J, Denis JC, Milpied N et al. Analysis of T cell receptor Vβ expression among Vα subsets. Evidence for tight regulation of the combinatorial diversity. Ann NY Acad Sci 1995; 756: 84-86.
10. Even J, Lim A, Puisieux L et al. T cell repertoire in healthy and diseased human tissues analysed by T cell receptor β chain CDR3 determination: evidence for clonal expansions in tumors and inflamatory diseases. Res Immunol 1996; 146: 65-80.
11. Pannetier C, Delassus S et al. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res 1993; 21: 577-583.
12. Pannetier C, Cochet M, Darche S et al. The size of the CDR3 hypervariable regions of the murine T cell receptor β chain vary as a function of the recombined germline segments. Proc Natl Acad Sci USA 1993; 90: 4319-4323.
13. Dietrich PY, Caignard A, Diu A et al. Analysis of T cell receptor variability in transplanted patient with graft-versus-host disease. Blood 1990; 80: 2419-2424.
14. Dietrich PY, Caignard A, Lim Chung Y et al. In vivo clonal amplification at time of graft versus host disease. Blood 1994; 84: 2815-2820.
15. Van Lochem EG, Bakker A, Snidjer S et al. Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a minor histocompatibility complex class-II-restricted proliferative T cell clone. Hum Immunol 1995; 42: 137-144.
16. Goulmy E, Shipper R, Pool L et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. New Engl J Med 1996; 334: 281-285.
17. Martin PJ. Increase disparity for minor histocompatibily antigens as potential cause of increased GVHD risk in marrow tranplantation from unrelated donors compared with related donors. Bone Marrow Transplant 1991; 8: 217-225.
18. Weiden PL, Sullivan KM, Flournoy N et al for the Seattle Marrow Transplant Team. Antileukemic effect of chronic graft-versus-host disease. Contribution for improved survival after allogeneic marrow transplantation. New Engl Med 1981; 304: 1529-1532.
19. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia after bone marrow transplantation. Blood 1990; 75: 555-562.
20. Kolb HJ, Shattenberg A, Goldman JM et al for the European Group for Blood and Marrow Transplantation. Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted recipient. Blood 1995; 86: 2041-2050.
21. Gallot G, Hallet MM, Gaschet J et al. Human HLA-specific T cell clones with stable expression of a suicide gene: a possible tool to drive and control a GVH-GVL reaction. Blood 1996; 88: 1098-1103.